[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]. [PDF]
Cheplyaeva NI +4 more
europepmc +1 more source
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]
Simanenkova AV +7 more
europepmc +1 more source
[Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms]. [PDF]
Dvoryanchikov YV +3 more
europepmc +1 more source
Теплота образования и молекулярная концентрация ионных соединений и их твердых растворов [PDF]
Иванкина, М. С. +1 more
core
[Pathogenetically justified use in real clinical practice of vaginal estriol 0.5 mg in women of different ages]. [PDF]
Andreeva EN +3 more
europepmc +1 more source
[Non-classical hormones from the fibroblast growth factor family]. [PDF]
Gronskaia SA +3 more
europepmc +1 more source
[Significance and methodology of monitoring calcemia in disorders of mineral metabolism: challenges and prospects]. [PDF]
Chubakova KA, Kamenskih EM, Saprina TV.
europepmc +1 more source
[Vitamin D deficiency in overweight patients: current strategies and practical aspects]. [PDF]
Karonova TL +13 more
europepmc +1 more source
[The relationship of constitutional-exogenous obesity and hormonalmicroelement status in adolescent boys with delayed sexual development]. [PDF]
Drukker NA +3 more
europepmc +1 more source
[Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo]. [PDF]
Sazonova DV +6 more
europepmc +1 more source

